Quest Diagnostics (DGX) Cash & Current Investments: 2009-2025
Historic Cash & Current Investments for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $432.0 million.
- Quest Diagnostics' Cash & Current Investments fell 43.46% to $432.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year decrease of 32.21%. This contributed to the annual value of $549.0 million for FY2024, which is 19.97% down from last year.
- According to the latest figures from Q3 2025, Quest Diagnostics' Cash & Current Investments is $432.0 million, which was up 35.42% from $319.0 million recorded in Q2 2025.
- In the past 5 years, Quest Diagnostics' Cash & Current Investments ranged from a high of $1.2 billion in Q1 2021 and a low of $126.0 million during Q2 2023.
- Its 3-year average for Cash & Current Investments is $375.2 million, with a median of $319.0 million in 2025.
- In the last 5 years, Quest Diagnostics' Cash & Current Investments plummeted by 84.05% in 2023 and then soared by 434.27% in 2024.
- Over the past 5 years, Quest Diagnostics' Cash & Current Investments (Quarterly) stood at $872.0 million in 2021, then slumped by 63.88% to $315.0 million in 2022, then spiked by 117.78% to $686.0 million in 2023, then decreased by 19.97% to $549.0 million in 2024, then tumbled by 43.46% to $432.0 million in 2025.
- Its Cash & Current Investments stands at $432.0 million for Q3 2025, versus $319.0 million for Q2 2025 and $188.0 million for Q1 2025.